What We Do

RevBio is a clinical stage company developing a regenerative, high-strength, injectable bone adhesive called Tetranite® that provides a new capability for surgeons to transform bone fixation and repair. Following rapid bonding to bone the material reabsorbs over the course of months and during this process the material’s osteo-promotive properties accelerate bone healing. The use of this unique material will reduce the duration and complexity of orthopedic and dental procedures, allow for more minimally invasive surgeries, and improve patient outcomes by reducing their pain, recovery time, and the overall cost of care. RevBio is developing a portfolio of specific applications across both dental and orthopaedics which address several large global market opportunities totaling over $10 billion.